http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2434633-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f96bf7eda4e4f6cb849af583adb82f1a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 |
| filingDate | 2007-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca8fbbab3b3b55047a104214194f9e24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46e2493030393c95f50ae819fc17bb45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34b9d924e98d30584af36def6e6eb3b1 |
| publicationDate | 2011-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2434633-C2 |
| titleOfInvention | Pharmaceutical preparative forms of latrunculin |
| abstract | FIELD: medicine, pharmaceutics. ^ SUBSTANCE: water pharmaceutical preparative form contains, at least, one latrunculin, non-ionic surface-active substance and preparation for supporting tonicity, at pH from 4 to 8. Latrunkulin, surface-active substance and preparation for supporting tonicity are compatible in preparative form, and preparative form does not contain more than 0.1% vol/vol dimethylsulfoxide. Latrunculin represents latrunculin A, latrunculin B, desmethyl latrunculin B or latrunculin analogue. Non-ionic surface-active substance is polysorbate, poloxamer or their combination. In accordance with the second version, water pharmaceutical form contains latrunculin, ethanol and preparation for supporting tonicity. Preparative form is intended for reduction of intraocular pressure in mammals. Preparative form by invention is stable during, at least, six months when cooled. ^ EFFECT: preparative form is intended for reduction of intraocular pressure in mammals. ^ 15 cl, 5 dwg, 7 ex |
| priorityDate | 2006-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 73.